Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kenneth Baillie

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
Science (New York, N.Y.)|May 24, 2014
Translational genomics. Targeting the host immune response to fight infectionJ Kenneth Baillie
Current Opinion in Investigational Drugs (London, England : 2000)|November 6, 2007
Activated protein C: controversy and hope in the treatment of sepsisJ Kenneth Baillie
Current Opinion in Investigational Drugs (London, England : 2000)|January 24, 2006
The mechanism of action of gabapentin in neuropathic painJ Kenneth Baillie, Ian Power
The New England Journal of Medicine|July 12, 2013
Influenza--time to target the host?J Kenneth Baillie, Paul Digard
The New England Journal of Medicine|June 24, 2005
Morphine, gabapentin, or their combination for neuropathic painJ Kenneth Baillie, Ian Power
American Journal of Respiratory and Critical Care Medicine|December 13, 2018
The Search for Efficacious New Therapies in Sepsis Needs to Embrace HeterogeneityBrendon P Scicluna, J Kenneth Baillie
Critical Care Medicine|May 3, 2021
Two Key Takeaways From a Year of Pandemic ResearchDavid M Maslove, J Kenneth Baillie
Current Opinion in Systems Biology|May 5, 2020
Treatable traits and therapeutic targets: Goals for systems biology in infectious diseaseClark D Russell, J Kenneth Baillie
European Journal of Anaesthesiology|August 27, 2009
Measurement errors caused by incompatibility of apparatusAdam Paul, J Kenneth Baillie, Gordon B Drummond
BMC Genomics|September 12, 2013
Modelling mutational and selection pressures on dinucleotides in eukaryotic phyla--selection against CpG and UpA in cytoplasmically expressed RNA and in RNA virusesPeter Simmonds, Wenjun Xia, J Kenneth Baillie, et al.
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
Science (New York, N.Y.)|May 24, 2014
Translational genomics. Targeting the host immune response to fight infectionJ Kenneth Baillie
Current Opinion in Investigational Drugs (London, England : 2000)|November 6, 2007
Activated protein C: controversy and hope in the treatment of sepsisJ Kenneth Baillie
Current Opinion in Investigational Drugs (London, England : 2000)|January 24, 2006
The mechanism of action of gabapentin in neuropathic painJ Kenneth Baillie, Ian Power
The New England Journal of Medicine|July 12, 2013
Influenza--time to target the host?J Kenneth Baillie, Paul Digard
The New England Journal of Medicine|June 24, 2005
Morphine, gabapentin, or their combination for neuropathic painJ Kenneth Baillie, Ian Power
American Journal of Respiratory and Critical Care Medicine|December 13, 2018
The Search for Efficacious New Therapies in Sepsis Needs to Embrace HeterogeneityBrendon P Scicluna, J Kenneth Baillie
Critical Care Medicine|May 3, 2021
Two Key Takeaways From a Year of Pandemic ResearchDavid M Maslove, J Kenneth Baillie
Current Opinion in Systems Biology|May 5, 2020
Treatable traits and therapeutic targets: Goals for systems biology in infectious diseaseClark D Russell, J Kenneth Baillie
European Journal of Anaesthesiology|August 27, 2009
Measurement errors caused by incompatibility of apparatusAdam Paul, J Kenneth Baillie, Gordon B Drummond
BMC Genomics|September 12, 2013
Modelling mutational and selection pressures on dinucleotides in eukaryotic phyla--selection against CpG and UpA in cytoplasmically expressed RNA and in RNA virusesPeter Simmonds, Wenjun Xia, J Kenneth Baillie, et al.
Pageof 19